X-Articles
85 *FREE* Articles Published on @BowtiedBiotech on X
June 17, 2025
mRNA Therapeutics 2025 & Beyond | Ep. 705
June 10, 2025
How to Maximize Returns Across Market Caps | Ep. 698
June 3, 2025
Radiopharma Renaissance: The Rise of Targeted Radiation Therapies | Ep. 692
May 27, 2025
Exploring the Transition from Founder to Traditional CEO
May 20, 2025
How VCs Are Adapting to a Changing Market | Ep. 678
May 13, 2025
The State of B-Cell Depletion Therapies: Is the Field Too Saturated? | Ep. 671
May 6, 2025
The Hottest Ticket in Town: High Profile Drug Targets With Biotech Roots | Ep. 664
April 29, 2025
Dual-Payload ADCs: The Next Frontier in Overcoming Resistance in Cancer | Ep. 657
April, 22, 2025
PLAUSIBLE MECHANISM, PLAUSIBLE PROFIT
April 15, 2025
Navigating the Complex Job Market in Biotech & Academia
April 8, 2025
Revolutionizing Healthcare With The Power of Digital Twins
April 1, 2025
Biotech’s Broken Incentive Machine
March 25, 2025
Biotech Startups Are Overtaking Academia?
March 18, 2025
Beyond CRISPR: Unlocking the Next Generation of Gene Editing Technologies
March 11, 2025
The Maturation of AI in Drug Discovery | Ep. 608
March 4, 2025
History Repeats Itself: Obesity vs. Immune-Oncology | Ep. 602
February 25, 2025
How Pharma and Biotech are Rewriting Healthcare | Ep. 595
February 18, 2025
Biotech History: The Hiring Surge of January 2022 | Ep. 588
February 11, 2025
In-Vivo CAR-T: Revolutionizing Cancer & Autoimmune Therapy
February 8, 2025
10 Ways Universities Can DOGE Impacts From Falling Indirect Cost Revenues | Ep. 577
February 4, 2025
Rising Stars in Drug Conjugates: AOCs vs. DACs | Ep. 572
January 28, 2025
The Impact of China’s Fast-Followers on Biotech M&A
January 21, 2025
Emerging Science from JPM 25 | Ep. 558
January 14, 2025
How Venture Capital Dried Up in China: Lessons from Biotech Deal-Making | Ep. 451
January 9, 2025
Has the Obesity Race Become Too Crowded? | Ep. 544
January 7, 2025
The Growing Trend of U.S. Biopharma Collaborating with China | Ep. 542
December 31, 2024
Startup Headcount as a Proxy for Biotech Health
December 30, 2024
Challenges and Opportunities in European VC Fundraising in 2024
December 24, 2024
The Odds of Biotechs Getting Acquired: Navigating the Path to Exit
December 23, 2024
Next-Generation Approaches to Modulate Biology Using Small Molecules
December 22, 2024
A DANISH DISASTER: Untangling Novo Nordisk from Denmark’s GDP
December 17, 2024
AI in Drug Target Discovery: A Peak into Tomorrow
December 9, 2024
2024: The Year of Biotech Insane Megarounds
December 3, 2024
Predicting the Next Big Biotech M&A: Trends, Timelines, and Top Candidates
November 29, 2024
Variability in Small Molecule GLP-1 Adverse Event-Related Discontinuations
November 26, 2024
The Race to Tackle Neuroinflammation in Modern Neuroscience
November 23, 2024
Tome Bio Post Mortem: L-PGI: Expanding the Boundaries of Precision Gene Editing
November 19, 2024
Leverage and Cash Recycling in Venture Capital: Amplifying Gains
November 12, 2024
Novartis' "Glue Degrader" Drug Candidate for Sickle Cell Disease Shows Promise
November 5, 2024
Venture Capital Strategy: Good vs. Great
November 4, 2024
Biotech Sector Strategies for Trading post-2024 Election Implications
November 2, 2024
Trump vs. Harris: Impacts on Biotech Under the 2024 US Presidential Election
October 29, 2024
Cash Runway Crisis and Reverse Mergers: The Growing Landscape of Financial Zombie Biotechs
October 15, 2024
How Do Venture Capitalists Make Decisions
October 8, 2024
The Venture Mirage: Why Surviving Isn’t Thriving in Startup Land
October 1, 2024
Rewiring the Rules of Biology: The Expanding Landscape of Inheritance and Translation
September 24, 2024
CAR-T vs Bispecifics: A Comparative Analysis
September 21, 2024
September 16, 2024
Why PD-(L)1 x VEGF Works: A Mechanistic Perspective
September 11, 2024
Trump vs. Harris: Impact on Biotech
September 8, 2024
Biopharma Job Openings: Top Companies Hiring Now
September 4, 2024
Biological Science Drives The Dawn of a New Space Age
August 31, 2024
Emerging Beyond GLP-1 Data from the Obesity Space
August 24, 2024
Rules for Investing in Platform Biotech Companies
August 21, 2024
The Rising Trend in Venture Capital of Capital Call Activity: An Indicator of Increasing Deal Flow
August 17, 2024
Inflation, Salaries, and the Startup Ecosystem: A Complex Interplay
August 4, 2024
Japan Stock Market Crash: Implications for the Biotech Sector
July 31, 2024
Next-Generation ADC (Antibody-Drug Conjugate) Development
July 24, 2024
Unleashing the Tumor-Fighting Potential of B Cells - Pan-Cancer Potential?
July 23, 2024
New Liquidity Option Emerges for Old VC Funds
July 20, 2024
Sleep & Risk of Chronic Disease
July 10, 2024
Dear Diary: Getting Biotech Financing Done in 2024
July 6, 2024
European Venture Capital Outperforms US Counterparts
July 3, 2024
The Post-COVID Era of Biotech Investing: Trends and Insights from Private Biotech Deal Making
July 1, 2024
Evaluating Danuglipron's New Formulations: Addressing Key Concerns
June 29, 2024
New Genetic Obesity Targets: A Promising Frontier in Weight Management
June 27, 2024
Beam Therapeutics: Leading the Charge in Genetic Medicine
June 25, 2024
Beyond GLP-1: Mono, Double, & Triple Combos Presented at ADA
June 22, 2024
Proforma Growth Strategy > Cash Flow Growth
June 17, 2024
Patient Case Study: Kyverna CD19 CAR-T in Multiple Sclerosis
June 15, 2024
Internal vs. External R&D: Leveraging Investment and Mitigating Risks
June 13, 2024
EULAR 2024: CAR-T For Auto-Immune Disease
June 13, 2024
The Impact of High Rent Prices on Biotech Workers in Major U.S. Cities
June 11, 2024
Green Light for Donanemab: Inside the AdCom's Unanimous Vote
June 10, 2024
A Tale of Three Technologies: PASSIGE, PASTE, & Gene Writing
June 9, 2024
Prime Medicine's Groundbreaking Prime Editing Therapy: A Leap Forward in Genetic Medicine
June 1, 2024
Epoch 14 - LifeStyle Drugs Coming from Biotech?
May 30, 2024
Biotech M&A: Change is in the Air?
May 18, 2024
Biotech Business Models - Platforms vs Assets
April 25, 2024
Innovation Recycling and Thematic Investing
March 24, 2024
How R&D Tax Incentives are Fueling Biotech Innovation in Australia
March 22, 2024
Researchers Advocate for Large-Scale RNome Project to Unlock the Power of RNA | Science
March 22, 2024
Scientists Uncover 'Backtracking': A New Mechanism for Genes Control in Cells
March 7, 2024
Hacking Biotech: Capital Allocation, Recycling, and Liquidation Preferences
March 7, 2024
